InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial

CGuard Carotid Stent will now be a treatment option in the stenting plus medical therapy arm of the trial for patients

Related Keywords

Australia ,United States ,Canada ,Israel ,Spain ,Thomas Brott ,Marvin Slosman ,Inspiremd Inc ,Drug Administration ,Embolic Prevention Stent System ,Carotid Stent ,Carotid Revascularizationendarterectomy ,Stenting Trial ,Investigational Device Exemption ,Chief Executive Officer ,Principal Investigator ,Carotid Revascularization ,Medical Management ,Asymptomatic Carotid Stenosis Trial ,Trial Identifier ,